Harry H. Mansbach - Feb 1, 2025 Form 4 Insider Report for 89bio, Inc. (ETNB)

Role
Chief Medical Officer
Signature
/s/ Ryan A. Murr, as attorney-in-fact for Harry H. Mansbach
Stock symbol
ETNB
Transactions as of
Feb 1, 2025
Transactions value $
-$32,045
Form type
4
Date filed
2/4/2025, 09:32 PM
Previous filing
Dec 16, 2024
Next filing
Feb 11, 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ETNB Common Stock Award $0 +80K +32.38% $0.00 327K Feb 1, 2025 Direct F1
transaction ETNB Common Stock Tax liability -$32K -3.34K -1.02% $9.60 324K Feb 1, 2025 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ETNB Stock Option (Right to Buy) Award $0 +320K $0.00 320K Feb 1, 2025 Common Stock 320K $9.60 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents restricted stock units that vest in equal semi-annual installments over three years, subject to the Reporting Person's continued service to the Issuer.
F2 These shares were withheld from the vesting of restricted stock units to cover the estimated tax withholding obligation.
F3 Represents a right to purchase a total of 320,000 shares of the Issuer's Common Stock, one quarter of which will vest on February 1, 2026, with the remaining three quarters vesting in equal quarterly installments over the following three years, subject to the Reporting Person's continued service to the Issuer.